A3 adenosine receptor-mediated protection of the ischemic heart (Q36142660)

12 August 2017

1 reference

title

A3 adenosine receptor-mediated protection of the ischemic heart (English)

1 reference

12 August 2017

John P Headrick

1 reference

12 August 2017

Jason Peart

series ordinal

1 reference

12 August 2017

publication date

19 April 2005

1 reference

12 August 2017

published in

Vascular Pharmacology

1 reference

12 August 2017

1 reference

12 August 2017

issue

5-6

1 reference

12 August 2017

page(s)

271-279

1 reference

Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvement

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Selective activation of A3 adenosine receptors with N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Canine Mast Cell Adenosine Receptors: Cloning and Expression of the A3Receptor and Evidence that Degranulation Is Mediated by the A2BReceptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

A3adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Functional role of intravascular coronary endothelial adenosine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Gene dosage-dependent effects of cardiac-specific overexpression of the A3 adenosine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

The late phase of preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Evidence for a role for both the adenosine A1 and A3 receptors in protection of isolated human atrial muscle against simulated ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Targeted deletion of A(3) adenosine receptors improves tolerance to ischemia-reperfusion injury in mouse myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

The adenosine transporter, mENT1, is a target for adenosine receptor signaling and protein kinase Cepsilon in hypoxic and pharmacological preconditioning in the mouse cardiomyocyte cell line, HL-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Ischemic preconditioning: from adenosine receptor to KATP channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Overexpression of A(3) adenosine receptors decreases heart rate, preserves energetics, and protects ischemic hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Preconditioning of rat hearts by adenosine A1 or A3 receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Tissue distribution of adenosine receptor mRNAs in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Endogenous adenosine mediates coronary vasodilation during exercise after K(ATP)+ channel blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Protective effects of adenosine in myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Gene dose-dependent atrial arrhythmias, heart block, and brady-cardiomyopathy in mice overexpressing A(3) adenosine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Mast cell-mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Pharmacology and therapeutic applications of A3 receptor subtype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Protective effects of adenosine in the perfused rat heart: changes in metabolism and intracellular ion homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Structure and function of adenosine receptors and their genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Inhibition of phenylephrine-induced cardiomyocyte hypertrophy by activation of multiple adenosine receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Effects of endogenous adenosine and adenosine receptor agonists on hypoxia-induced myocardial stunning in Guinea-pig atria and papillary muscles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Characterization of ERK1/2 signalling pathways induced by adenosine receptor subtypes in newborn rat cardiomyocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Activation of protein kinase B by adenosine A1 and A3 receptors in newborn rat cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Ischemic preconditioning prevents the impairment of hypoxic coronary vasodilatation caused by ischemia/reperfusion: role of adenosine A1/A3 and bradykinin B2 receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Adenosine protects against angiotensin II-induced apoptosis in rat cardiocyte cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

K(ATP) opener-induced delayed cardioprotection: involvement of sarcolemmal and mitochondrial K(ATP) channels, free radicals and MEK1/2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Targeted deletion of the A3 adenosine receptor confers resistance to myocardial ischemic injury and does not prevent early preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Effects of A(3) adenosine receptor activation and gene knock-out in ischemic-reperfused mouse heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Coronary endothelial dysfunction increases the severity of ischaemia-induced ventricular arrhythmias in rat isolated perfused hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Ischemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Acute adenosinergic cardioprotection in ischemic-reperfused hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Relative importance of adenosine A1 and A3 receptors in mediating physiological or pharmacological protection from ischemic myocardial injury in the rabbit heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Role of adenosine receptor activation in antioxidant enzyme regulation during ischemia-reperfusion in the isolated rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Adenosine A3 receptors: novel ligands and paradoxical effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

A(3) adenosine receptor activation attenuates neutrophil function and neutrophil-mediated reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Adenosine receptors: G protein-mediated signalling and the role of accessory proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Cyclooxygenase-2 does not mediate late preconditioning induced by activation of adenosine A1 or A3 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

A novel cardioprotective role of RhoA: new signaling mechanism for adenosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Dual signaling via protein kinase C and phosphatidylinositol 3'-kinase/Akt contributes to bradykinin B2 receptor-induced cardioprotection in guinea pig hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

A physiological role of the adenosine A3 receptor: sustained cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

The role of adenosine and ATP-sensitive potassium channels in the protection afforded by ischemic preconditioning against the post-ischemic endothelial dysfunction in guinea-pig hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Adenosine A(3) receptor activation protects the myocardium from reperfusion/reoxygenation injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Protection from myocardial stunning by ischaemia and hypoxia with the adenosine A3 receptor agonist, IB-MECA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Adenosine acts as an endogenous activator of the cellular antioxidant defense system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Adenosine enhanced preservation of myocardial function and energetics. Possible involvement of the adenosine A1 receptor system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Adenosine receptor subtypes: characterization and therapeutic regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Differential interaction with and regulation of multiple G-proteins by the rat A3 adenosine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Distinct cardioprotective effects of adenosine mediated by differential coupling of receptor subtypes to phospholipases C and D.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Adenosine-mediated early preconditioning in mouse: protective signaling and concentration dependent effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Adenosine-mediated cardioprotection in ischemic-reperfused mouse heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Adenosine A3 receptor activation modulates the capillary endothelial glycocalyx

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Acetylcholine but not adenosine triggers preconditioning through PI3-kinase and a tyrosine kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Cardioprotective effects of adenosine A1 and A3 receptor activation during hypoxia in isolated rat cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Signalling from adenosine receptors to mitogen-activated protein kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Adenosine and Adenosine Receptors in the Cardiovascular System: Biochemistry, Physiology, and Pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Adenosine and cardioprotection during ischaemia and reperfusion--an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Delayed adaptation of the heart to stress: late preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

A(1) or A(3) adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Src family kinase and adenosine differentially regulate multiple MAP kinases in ischemic myocardium: modulation of MAP kinases activation by ischemic preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Adenosine A(3)-receptor stimulation attenuates postischemic dysfunction through K(ATP) channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Adenosine A3 pretreatment before cardioplegic arrest attenuates postischemic cardiac dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Selective adenosine A3 receptor stimulation reduces ischemic myocardial injury in the rabbit heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Selective activation of adenosine A3 receptors with N6-(3-chlorobenzyl)-5'-N-methylcarboxamidoadenosine (CB-MECA) provides cardioprotection via KATP channel activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Aldose reductase inhibition alone or combined with an adenosine A(3) agonist reduces ischemic myocardial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Novel N6-substituted adenosine 5'-N-methyluronamides with high selectivity for human adenosine A3 receptors reduce ischemic myocardial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Cloned receptors and cardiovascular responses to adenosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Broad-spectrum cardioprotection with adenosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Dual activation of adenosine A1 and A3 receptors mediates preconditioning of isolated cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Mediators of coronary reactive hyperaemia in isolated mouse heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Late preconditioning elicited by activation of adenosine A(3) receptor in heart: role of NF- kappa B, iNOS and mitochondrial K(ATP) channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

A3 adenosine receptor stimulation modulates sarcoplasmic reticulum Ca(2+) release in rat heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

Cardiac myocytes rendered ischemia resistant by expressing the human adenosine A1 or A3 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VPH.2005.02.009

1 reference

12 August 2017

1 reference